Statements (58)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:virus
|
gptkbp:associated_with |
animal welfare concerns
trade restrictions economic losses in agriculture |
gptkbp:caused_by |
gptkb:healthcare_organization
|
gptkbp:clinical_trial |
field trials
neurological symptoms ongoing studies vaccine trials therapeutic trials reproductive failure abortion in pregnant animals |
gptkbp:controls |
vaccination campaigns
surveillance programs quarantine protocols biosecurity practices |
gptkbp:family |
gptkb:Arteriviridae
|
gptkbp:genus |
gptkb:Arterivirus
|
gptkbp:healthcare |
concerns for zoonotic diseases
monitoring required for outbreaks significant in livestock industries |
gptkbp:hosts |
gptkb:horse_race
pigs |
https://www.w3.org/2000/01/rdf-schema#label |
Arterivirus
|
gptkbp:is_protected_by |
vaccination
|
gptkbp:is_recognized_by |
Equine Arteritis Virus
|
gptkbp:is_vulnerable_to |
inactivated vaccine
live attenuated vaccine boosters recommended immunity duration varies variable among strains |
gptkbp:publishes |
cytoplasm
|
gptkbp:related_to |
Porcine Reproductive and Respiratory Syndrome Virus
Simian Hemorrhagic Fever Virus |
gptkbp:research_focus |
vaccine development
viral genetics pathogenesis studies host interactions |
gptkbp:seed_dispersal |
single-stranded RNA
|
gptkbp:social_responsibility |
serological tests
PCR tests zoonotic potential high in certain hosts |
gptkbp:symptoms |
fever
respiratory distress edema |
gptkbp:transmission |
vertical transmission
bodily fluids horizontal transmission respiratory secretions |
gptkbp:treatment |
anti-inflammatory medications
supportive care antiviral drugs |
gptkbp:year_created |
1950s
|
gptkbp:bfsParent |
gptkb:Arteriviridae
gptkb:Equine_arteritis_virus gptkb:Porcine_reproductive_and_respiratory_syndrome_virus |
gptkbp:bfsLayer |
6
|